Compare · CRKN vs DHR
CRKN vs DHR
Side-by-side comparison of Crown Electrokinetics Corp. (CRKN) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- CRKN operates in Technology, while DHR operates in Industrials - the two are in different parts of the market.
- DHR is the larger of the two at $125.45B, about 3252.0x CRKN ($38.6M).
- Over the past year, CRKN is up 0.0% and DHR is down 9.6% - CRKN leads by 9.6 points.
- DHR has hit the wire 8 times in the past 4 weeks while CRKN has been quiet.
- DHR has more recent analyst coverage (25 ratings vs 1 for CRKN).
- Company
- Crown Electrokinetics Corp.
- Danaher Corporation
- Price
- $1.82-46.78%
- $177.21-0.75%
- Market cap
- $38.6M
- $125.45B
- 1M return
- +0.00%
- -5.33%
- 1Y return
- +0.00%
- -9.57%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 8
- Recent ratings
- 1
- 25
Crown Electrokinetics Corp.
Crown Electrokinetics Corp. focuses on commercializing electrokinetic technology for use in the smart glass market. The company offers electrokinetic film technology for smart or dynamic glass. It develops and sells optical switching films. The company was formerly known as 3D Nanocolor Corp. and changed its name to Crown ElectroKinetics Corp. in October 2017. Crown ElectroKinetics Corp. was incorporated in 2015 and is based in Corvallis, Oregon.
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest CRKN
- Crown Electrokinetics Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- Crown Electrokinetics Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
- Crown Fiber Optics Announces $100 Million in Secured Multi-Year Fiber Contracts
- Crown Electrokinetics Corp. filed SEC Form 8-K: Leadership Update
- Crown Electrokinetics Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant
- Crown Electrokinetics Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Crown Appoints Chris Robichaud to Board of Directors
- SEC Form NT 10-Q filed by Crown Electrokinetics Corp.
- SEC Form 25 filed by Crown Electrokinetics Corp.
- Crown Electrokinetics Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Latest DHR
- SEC Form 424B5 filed by Danaher Corporation
- Danaher Announces Pricing of Euro-Denominated Senior Notes Offering
- SEC Form FWP filed by Danaher Corporation
- SEC Form 424B5 filed by Danaher Corporation
- Danaher Reports First Quarter 2026 Results
- Danaher Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement
- Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Amendment: SEC Form SCHEDULE 13G/A filed by Danaher Corporation
- SEC Form DEFA14A filed by Danaher Corporation